Using Salsalate to Target Adipocyte Macrophage Infiltration

NCT02130804 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Risk

Interventions

DRUG: Salsalate (4 g/day)
DRUG: Placebo (4 g/day)

Sponsor

University of Southern California